切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2021, Vol. 14 ›› Issue (02) : 184 -188. doi: 10.3877/cma.j.issn.1674-6902.2021.02.010

论著

S-腺苷甲硫氨酸抑制miR-34a依赖的肺癌转移的作用
彭小乐1, 郭东2, 林佳鹤3, 胡小强1, 靳凯悦1, 王建云1,()   
  1. 1. 101200 北京,首都医科大学附属北京友谊医院平谷医院心胸外科
    2. 101200 北京,北京安贞医院心外科
    3. 101200 北京,首都医科大学附属北京友谊医院平谷医院麻醉科
  • 收稿日期:2020-10-15 出版日期:2021-04-25
  • 通信作者: 王建云
  • 基金资助:
    北京市医院管理局"登峰"计划专项经费资助(DFL20180602)

Role of S-adenosylmethionine in suppressing mir-34a dependent lung cancer metastasis

Xiaole Peng1, Dong Guo2, Jiahe Lin3, Xiaoqiang Hu1, Kaiyue Jin1, Jianyun Wang1,()   

  1. 1. Department of Cardiothoracic Surgery, Pinggu Hospital, Beijing Friendship Hospital, Capital Medical University, Beijing 101200, China
    2. Department of Cardiac Surgery, Beijing Anzhen Hospital, Beijing 101200, China
    3. Department of Anesthesiology, Pinggu Hospital, Beijing Friendship Hospital, Capital Medical University, Beijing 101200, China
  • Received:2020-10-15 Published:2021-04-25
  • Corresponding author: Jianyun Wang
引用本文:

彭小乐, 郭东, 林佳鹤, 胡小强, 靳凯悦, 王建云. S-腺苷甲硫氨酸抑制miR-34a依赖的肺癌转移的作用[J]. 中华肺部疾病杂志(电子版), 2021, 14(02): 184-188.

Xiaole Peng, Dong Guo, Jiahe Lin, Xiaoqiang Hu, Kaiyue Jin, Jianyun Wang. Role of S-adenosylmethionine in suppressing mir-34a dependent lung cancer metastasis[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2021, 14(02): 184-188.

目的

探讨S-腺苷甲硫氨酸抑制miRNA-34a依赖的肺癌转移机制。

方法

选取肺癌细胞A549,分别采用0、50、100、200、500 μM的S-腺苷甲硫氨酸(S-adenosylmethionine, SAMe)刺激A549细胞并检测miR-34a以及下游STAT3信号通路的表达情况,同时检测不同刺激条件下A549细胞的侵袭转移情况;实时荧光定量(real-time fluorescence quantification, qPCR)检测miR-34a、E-cadherin、α-catenin、N-cadherin、Vimentin的mRNA表达水平;Western Blot实验检测STAT3、p-STAT3、β-actin的表达水平;Transwell实验检测A549细胞的侵袭能力变化。

结果

随着SAMe浓度的增加,miR-34a的表达水平呈梯度增加,与对照组相比,经t检验分析,差异有统计学的意义(P<0.05);Western Blot实验显示,与对照组相比,500 μM SAMe刺激后,下游的p-STAT3蛋白水平下降,总STAT3和内参蛋白β-actin水平不变;qPCR结果显示,随着药物浓度的增加,表皮蛋白E-cadherin、α-catenin的mRNA水平上升,间质蛋白N-cadherin、Vimentin的mRNA水平下降;Transwell实验显示经50、100、200、500 μM的SAMe刺激后,A549细胞的侵袭转移抑制率分别为18.70%、31.24%、47.66%、58.46%,与对照组相比,经t检验分析,差异有统计学的意义(P<0.05)。

结论

SAMe可通过抑制miR-34a依赖的下游STAT3信号通路抑制肺癌细胞的侵袭转移,提示SAMe在肺癌侵袭转移过程中发挥重要作用。

Objective

To investigate the molecular mechanisms of S-adenosine methionine in suppressing lung cancer metastasis with a miRNA-34a-dependent manner.

Methods

A549 lung cancer cell was selected as the study model of this time research. A549 cells were stimulated with 0, 50, 100, 200, 500 μM SAMe, respectively and the expression of miR-34a and its related STAT3 signaling pathways were also detected. The invasive capacity of cells was detected under various condition as well; miR-34a, E-cadherin, α-catenin, N-cadherin and Vimentin mRNA expression were detected by qPCR method; Western Blot was used to detect expression of STAT3, p-STAT3 and β-actin; Invasive capacity of A549 cells was detected by Transwell experiment.

Results

As the increase of SAMe concentration, miR-34a expression increased gradually, and when it was compared to the control group, the difference was statistically significant through the t-test (P<0.05); Western Blot experiments showed that p-STAT3 protein level of 500 μM SAMe stimulation was lower than 0 μM treatment, while total STAT3 and β-actin level had no change; q-PCR results showed that E-cadherin and α-catenin level elevated, but N-cadherin and Vimentin level decreased as the increase of drug concentration; Transwell experiments showed that invasive inhibitory rates of A549 cells in 50, 100, 200, 500 μM of SAMe were 18.70%, 31.24%, 47.66% and 58.46%, respectively. And compared to the control group, the difference had statistical significance by t-tset (P<0.05).

Conclusion

SAMe could suppress cell metastasis through a miR-34a-dependent manner by inhibiting STAT3 signaling pathway in lung cancer cells, which suggested a potential role of SAMe in metastasis of lung cancer.

表1 Q-PCR引物序列
图1 SAMe诱导miR-34a的表达;注:*与对照组相比,差异有统计学意义,P<0.05
图2 SAMe处理后STAT3信号通路的变化
表2 蛋白灰度分析结果
图3 不同浓度SAMe处理A549细胞的侵袭抑制率;注:*与对照组相比,差异有统计学意义,P<0.05;**与对照组相比,差异有统计学意义,P<0.01
图4 SAMe抑制肺癌细胞的转移;注:A:0 μM SAMe处理;B:500 μMSAMe处理
图5 A549细胞表皮间质标志物变化;注:*与对照组相比,差异有统计学意义,P<0.05;**与对照组相比,差异有统计学意义,P<0.01
1
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
2
任成山,白 莉,钱桂生. 慢性阻塞性肺疾病合并肺癌临床特征及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(2): 137-142.
3
赵邱煜,信 涛. 非小细胞肺癌脑膜转移治疗的研究进展[J]. 医学综述,2021, 27(02):303-307.
4
Hoffman PC, Mauer AM, Vokes EE. Lung cancer[J]. Lancet, 2000, 355(9202): 479-85.
5
Yoder LH. Lung cancer epidemiology[J]. Medsurg Nurs, 2006, 15(3): 171-174.
6
Chen W, Zheng R, Zeng H, et al. Epidemiology of lung cancer in China[J]. Thorac Cancer, 2015, 6(2): 209-15.
7
Keshamouni V, Arenberg D, Kalemkerian G. Lung Cancer Metastasis[M]. 2010.
8
茆春国,邓 波. 肺癌循环肿瘤细胞侵袭转移机制的研究进展[J].中国肺癌杂志,2020, 23(03): 189-195.
9
朱 丽,龚 波. 下调miR-4262抑制肺癌细胞A549转移潜能的机制[J].分子诊断与治疗杂志,2020, 12(10): 1375-1379.
10
郭梦玲,王熙才,陈 艳. 外泌体miRNA与肺癌的发生发展[J]. 中国肿瘤生物治疗杂志,2020, 27(04): 457-462.
11
余昌敏,张 丹,闵 明,等. 外泌体miRNA作为癌症早期诊断标志物的研究进展[J]. 中国免疫学杂志,2020, 36(22): 2786-2790.
12
Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks[J]. Nature cell biology, 2013, 15(6): 546-554.
13
Tang Y, Tang Y, Cheng YS. miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway[J]. Sci Rep, 2017, 7: 38232.
14
张月朋,陈复辉. miR-34在非小细胞肺癌中研究进展[J]. 中华实用诊断与治疗杂志,2020, 34(06): 643-645.
15
刘 罡,毛重山. miR-34a靶向CD44对肺癌细胞干细胞表型的影响[J]. 中国老年学杂志,2019, 39(10): 2477-2480.
16
王鑫元,国 强,常哲瀚,等. 奥沙利铂通过调控P53、miR-34a抑制胃癌细胞的增殖[J]. 包头医学院学报,2020, 36(10): 67-70+121.
17
Li XJ, Zhang W, Xu K, et al. miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway[J]. Pathol Res Pract, 2020,216(5): 152876.
18
梁 辰,王 萍,金由辛,等. p53/miR-34a调控网络在肿瘤中的作用[J]. 生命科学,2016, 28(04): 464-469.
19
Zhu H, Chang LL, Yan FJ, et al. AKR1C1 activates STAT3 to promote the metastasis of non-small cell lung cancer[J]. Theranostics, 2018, 8(3): 676-92.
20
Wang AS, Duan GX, Zhao CL, et al. Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation[J]. Oncol Lett, 2017, 13(5): 3039-3045.
21
茹泽园. 肺癌细胞外泌体通过其携带的IL-6介导的STAT3途径诱导肌管萎缩的机制研究[D]. 华中科技大学,2019.
22
Chiang PK, Gordon RK, TAL J, et al. S-Adenosylmethionine and methylation[J]. Faseb J, 1996, 10(4): 471-480.
23
刘绍文. S-腺苷甲硫氨酸(SAMe)对人肝内胆管癌细胞系ICC-9810增殖及迁移能力的影响及作用机制[D]. 皖南医学院,2019.
24
Palmisano WA. DNA methylation markers and early recurrence in stage i lung cancer[J]. N Engl J Med, 2008, 358(11): 1118-1128.
25
孙东峰,田 辉,刘贤锡,等. 鸟氨酸脱羧酶和S-腺苷甲硫氨酸脱羧酶双反义腺病毒对肺癌增殖和侵袭抑制作用的研究[J]. 中华外科杂志,2008, 46(1): 61-64.
26
Torre LA, Siegel RL, Jemal A. Lung cancer statistics[J]. Adv Exp Med Biol, 2016, 893: 1-19.
27
Faure M. Lung cancer in Europe: turning the spotlight on the biggest cancer killer[J]. Eur Respir J, 2016, 47(1): 42-4.
28
范 伟. S-腺苷甲硫氨酸抑制非小细胞性肺癌增殖,侵袭,转移的机制[D]. 广州医科大学,2018.
29
宋伟祥,卢 伟. 腺苷蛋氨酸在肠癌肝转移患者化疗期间的护肝作用[J]. 肿瘤研究与临床,2011(12): 847-848.
30
刘 敏. S-腺苷甲硫氨酸脱羧酶基因表达与大肠癌关系的研究[D]. 山东大学,2006.
31
Zhang F, Wang B, Qin T, et al. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation[J]. Mol Cell Biochem, 2020, 473(1-2): 1-3.
32
Rokavec M, Oner MG, Li H, et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis[J]. J Clin Invest, 2014, 124(4): 1853-1867.
[1] 梁开地, 缑文斌, 莫居容. 肺癌组织中细胞角蛋白18的表达及与预后的相关性[J]. 中华肺部疾病杂志(电子版), 2023, 16(05): 688-690.
[2] 蒙姣姣, 胡刚, 欧阳涣堃. 肺癌术前淋巴结转移及MWA手术效果预测分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 547-549.
[3] 王玉琳, 孙晓容. 晚期肺癌大咯血输注垂体后叶素渗漏救治成功一例[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 451-452.
[4] 徐欣轶, 薛蓓, 蒋莉, 陈慧. NRI联合CFS评分对肺癌术后机械通气的预测分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 358-360.
[5] 黄芳芳, 陈雅玫, 邓牡红, 石新华, 尚少梅. 肺癌患者上肢PICC相关性静脉血栓危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 324-328.
[6] 陶梅梅, 王新霞, 朱光发. 肺癌并发心律失常临床特点及支气管镜检查安全性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 180-184.
[7] 张宁, 周明明, 蒋正英, 吴桂新, 吕奇坤. 肺癌合并脓毒症mHLA-DR、CD39+Treg及IL-10表达与预后相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 169-174.
[8] 潘玥, 夏婷, 王燕, 顾娟. 肺结节患者生活质量影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 272-274.
[9] 褚依然, 岳麓. 液体活检技术在肺癌中的应用进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 125-127.
[10] 刘晓青, 张雪玲, 刘权兴, 罗茂雨, 戴纪刚. 肺癌术后不同时机拔除胸腔引流管临床结局比较的网状Meta分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 787-791.
[11] 王冠, 徐兴祥. 吸入药物在慢性阻塞性肺疾病和肺癌中的应用及进展[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 904-907.
[12] 高雪松, 刘慧慧, 张习巨. 经支气管针吸活检细胞黏附分子CD56、甲状腺转录因子-1水平与肺癌组织分型关系分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 873-875.
[13] 吴一帆, 魏磊, 苏惠斌, 杨芬. 小剂量艾司氯胺酮对肺癌胸腔镜手术后抑郁及功能恢复的影响[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 856-858.
[14] 陈明星, 邹志杰, 徐军发. 胸水及血清中透明质酸水平在肺癌与肺良性疾病中的鉴别诊断意义[J]. 中华肺部疾病杂志(电子版), 2022, 15(04): 509-511.
[15] 韦先梅, 韩毓, 蒋英彩. 敲减circSERPINE2通过靶向调控miR-34a-5p表达抑制滋养层细胞增殖、迁移和侵袭[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 193-201.
阅读次数
全文


摘要